Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Clostridium butyricum

ABSTRACT: Reading of fecal original sequence of mice with Parkinson's disease

PROVIDER: PRJNA1170074 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31145443.fastq.gz	Fastqsanger.gz
	SRR31145444.fastq.gz	Fastqsanger.gz
	SRR31145445.fastq.gz	Fastqsanger.gz
	SRR31145446.fastq.gz	Fastqsanger.gz
	SRR31145447.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 35

Similar Datasets

Sus scrofa

Project description:Original sequence reading of piglet fecal microbiota

| PRJNA1014233 | ENA

mice gut metagenome

Project description:Reading the original sequence of intestinal flora in mice

| PRJNA806383 | ENA

Clostridium butyricum

Project description:Clostridium butyricum Raw sequence reads

| PRJNA1022519 | ENA

Clostridium butyricum

Project description:Clostridium butyricum Raw sequence reads

| PRJNA1054763 | ENA

Clostridium butyricum

Project description:Clostridium butyricum Raw sequence reads

| PRJNA682776 | ENA

Clostridium butyricum

Project description:Clostridium butyricum Raw sequence reads

| PRJNA1025233 | ENA

Project description:fecal microbial composition in Parkinson's disease

| PRJNA1127293 | ENA

FMT study

Project description:Fecal microbiota transplantation in Parkinson's disease

| PRJEB68317 | ENA

Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan.

Project description:Clostridium butyricum, a probiotic commonly prescribed in Asia, most notably as MIYA-BM (Miyarisan Pharmaceutical Co., Ltd.; https://www.miyarisan.com), occasionally leads to bacteremia. The prevalence and characteristics of C. butyricum bacteremia and its bacteriologic and genetic underpinnings remain unknown. We retrospectively investigated patients admitted to Osaka University Hospital during September 2011-February 2023. Whole-genome sequencing revealed 5 (0.08%) cases of C. butyricum bacteremia among 6,576 case-patients who had blood cultures positive for any bacteria. Four patients consumed MIYA-BM, and 1 patient consumed a different C. butyricum-containing probiotic. Most patients had compromised immune systems, and common symptoms included fever and abdominal distress. One patient died of nonocclusive mesenteric ischemia. Sequencing results confirmed that all identified C. butyricum bacteremia strains were probiotic derivatives. Our findings underscore the risk for bacteremia resulting from probiotic use, especially in hospitalized patients, necessitating judicious prescription practices.

| S-EPMC10977840 | biostudies-literature

Project description:Fecal microbiota of patients with Parkinson's disease

| PRJNA1159471 | ENA